Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3-CD70-CD27+IgM+CD43+CD5+/-

Vaccine

Volumn 31, Issue 41, 2013, Pages 4632-4640

  Leggat, David J ^a   Khaskhely, Noor M ^a   Iyer, Anita S ^a   Mosakowski, Jason ^a   Thompson, Rebecca S ^a   Weinandy, John D ^a   Westerink, M A Julie ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

B cell; CD43; Flow cytometry; Pneumococcus; Polysaccharide; Streptococcus pneumoniae

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD70 ANTIGEN; IMMUNOGLOBULIN M; LEUKOSIALIN; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL POPULATION; COMPARATIVE STUDY; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOPHENOTYPING; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; VACCINATION;

AB; ANTIBODIES; B CELL; CD43; FLOW CYTOMETRY; FLUORESCENCE MINUS ONE; FMO; MZB; OPSONOPHAGOCYTIC TITER; OPT; PNEUMOCOCCAL POLYSACCHARIDE; PNEUMOCOCCAL POLYSACCHARIDE VACCINATION; PNEUMOCOCCUS; POLYSACCHARIDE; PPS; PPV; SPLENIC MARGINAL ZONE B CELL; STREPTOCOCCUS PNEUMONIAE; T-INDEPENDENT TYPE II; TI-2;

ADULT; ANTIGENS, CD; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; MALE; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; YOUNG ADULT;

EID: 84883599978     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.030     Document Type: Article

References (44)

1. Song J.H., Dagan R., Klugman K.P., Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012, 30:2728-2737.
2. van der Poll T., Opal S.M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009, 374:1543-1556.
3. Westerink M.A., Schroeder H.W., Nahm M.H. Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination. Aging and Disease 2012, 3:51-67.
4. Heffernan R.T., Barrett N.L., Gallagher K.M., Hadler J.L., Harrison L.H., Reingold A.L., et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. Journal of Infectious Diseases 2005, 191:2038-2045.
5. Breiman R.F., Spika J.S., Navarro V.J., Darden P.M., Darby C.P. Pneumococcal bacteremia in Charleston County, South Carolina A decade later. Archives of Internal Medicine 1990, 150:1401-1405.
6. Garcia-Suarez Mdel M., Vazquez F., Mendez F.J. Streptococcus pneumoniae virulence factors and their clinical impact: an update. Enfermedades Infecciosas y Microbiología Clínica 2006, 24:512-517.
7. Taillardet M., Haffar G., Mondiere P., Asensio M.J., Gheit H., Burdin N., et al. The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood 2009, 114:4432-4440.
8. Musher D.M., Manof S.B., Liss C., McFetridge R.D., Marchese R.D., Bushnell B., et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. Journal of Infectious Diseases 2010, 201:516-524.
9. Musher D.M., Manoff S.B., McFetridge R.D., Liss C.L., Marchese R.D., Raab J., et al. Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Human Vaccines 2011, 7:919-928.
10. Ortqvist A. Pneumococcal vaccination: current and future issues. European Respiratory Journal 2001, 18:184-195.
11. Wartha F., Beiter K., Albiger B., Fernebro J., Zychlinsky A., Normark S., et al. Capsule and d-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cellular Microbiology 2007, 9:1162-1171.
12. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
13. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy Possible contribution to the deficient infant immune response. Journal of Immunology 1989, 143:3200-3206.
14. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004, 104:3647-3654.
15. Zandvoort A., Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clinical & Experimental Immunology 2002, 130:4-11.
16. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annual Review of Immunology 2009, 27:267-285.
17. Puga I., Cols M., Barra C.M., He B., Cassis L., Gentile M., et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature Immunology 2012, 13:170-180.
18. Shi Y., Yamazaki T., Okubo Y., Uehara Y., Sugane K., Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. Journal of Immunology 2005, 175:3262-3267.
19. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. Journal of Experimental Medicine 2003, 197:939-945.
20. Hart M., Steel A., Clark S.A., Moyle G., Nelson M., Henderson D.C., et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. Journal of Immunology 2007, 178:8212-8220.
21. Alugupalli K.R., Leong J.M., Woodland R.T., Muramatsu M., Honjo T., Gerstein R.M. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 2004, 21:379-390.
22. Haas K.M., Poe J.C., Steeber D.A., Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005, 23:7-18.
23. Defrance T., Taillardet M., Genestier L. T cell-independent B cell memory. Current Opinion in Immunology 2011, 23:330-336.
24. Haas K.M. Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens. Journal of Immunology 2011, 187:5183-5195.
25. Obukhanych T.V., Nussenzweig M.C. T-independent type II immune responses generate memory B cells. Journal of Experimental Medicine 2006, 203:305-310.
26. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
27. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nature Reviews Immunology 2011, 11:34-46.
28. Carsetti R., Rosado M.M., Wardmann H. Peripheral development of B cells in mouse and man. Immunological Reviews 2004, 197:179-191.
29. Lee J., Kuchen S., Fischer R., Chang S., Lipsky P.E. Identification and characterization of a human CD5+ pre-naive B cell population. Journal of Immunology 2009, 182:4116-4126.
30. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. Journal of Experimental Medicine 2011, 208:67-80.
31. Khaskhely N., Mosakowski J., Thompson R.S., Khuder S., Smithson S.L., Westerink M.A. Phenotypic analysis of pneumococcal polysaccharide-specific B cells. Journal of Immunology 2012, 188:2455-2463.
32. Verbinnen B., Covens K., Moens L., Meyts I., Bossuyt X. Human CD20+CD43+CD27+CD5- B cells generate antibodies to capsular polysaccharides of Streptococcus pneumoniae. Journal of Allergy and Clinical Immunology 2012, 130:272-275.
33. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells are CD3-: a reply to "A human equivalent of mouse B-1 cells?" and "The nature of circulating CD27+CD43+ B cells". Journal of Experimental Medicine 2011, 208:2566-2569.
34. Griffin D.O., Rothstein T.L. Human b1 cell frequency: isolation and analysis of human b1 cells. Frontiers in Immunology 2012, 3:122.
35. Concepcion N.F., Frasch C.E. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology 2001, 8:266-272.
36. Moon Nahm D.G. Training manual for Enzyme linked immunosorbent assay for the quantitation of Streptococcus pneumoniae serotype specific IgG (Pn Ps ELISA). (89SF Version) 2006, World Health Organization.
37. Moon Nahm D.G. Training manual for Enzyme linked immunosorbent assay for the quantitation of Streptococcus pneumoniae serotype specific IgG (Pn Ps ELISA). (007 Version) 2011, 1-29. World Health Organization.
38. Romero-Steiner S., Libutti D., Pais L.B., Dykes J., Anderson P., Whitin J.C., et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clinical and Diagnostic Laboratory Immunology 1997, 4:415-422.
39. Kolibab K., Smithson S.L., Shriner A.K., Khuder S., Romero-Steiner S., Carlone G.M., et al. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults I. Antibody concentrations, avidity and functional activity. Immunity & Ageing 2005, 2:10.
40. Nahm M.G.D. Training manual for enzyme linked immunosobent assay for the quantitation of Streptococcus pneumoniae serotype specific IgG (PnPg ELISA) 2002, World Health Organization.
41. Park S., Nahm M.H. Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infection and Immunity 2011, 79:314-320.
42. Go E.S., Ballas Z.K. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. Journal of Allergy and Clinical Immunology 1996, 98:205-215.
43. Moens L., Wuyts M., Meyts I., De Boeck K., Bossuyt X. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response. Journal of Immunology 2008, 181:5306-5312.
44. Leggat D.J., Thompson R.S., Khaskhely N.M., Iyer A.S., Westerink M.A. The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells. Journal of Infectious Diseases 2013.